A detailed history of Enterprise Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Enterprise Bank & Trust CO holds 2,278 shares of ABBV stock, worth $410,040. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,278
Previous 2,379 4.25%
Holding current value
$410,040
Previous $408,000 10.05%
% of portfolio
0.15%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$163.84 - $199.33 $16,547 - $20,132
-101 Reduced 4.25%
2,278 $449,000
Q1 2024

Apr 10, 2024

BUY
$159.82 - $182.1 $799 - $910
5 Added 0.21%
2,379 $433,000
Q4 2023

Jan 09, 2024

BUY
$137.6 - $154.97 $326,662 - $367,898
2,374 New
2,374 $367,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Enterprise Bank & Trust CO Portfolio

Follow Enterprise Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Bank & Trust CO with notifications on news.